版本:
中国

BRIEF-Acorda Therapeutics plans to file NDA for Inbrija with U.S. FDA by end of Q2

May 18 Acorda Therapeutics Inc

* Acorda Therapeutics - plans to file a new drug application for inbrija with U.S. FDA by end of Q2 of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐